AnaptysBio Inc (ANAB.OQ)
ANAB.OQ on NASDAQ Stock Exchange Global Select Market
65.03USD
20 Feb 2019
65.03USD
20 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$65.03
$65.03
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
117,860
117,860
52-wk High
$134.00
$134.00
52-wk Low
$54.38
$54.38
About
AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $725.82 |
| Shares Outstanding(Mil.): | 20.34 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ANAB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -1.06 | -- | -- |
| ROI: | -23.31 | 8.92 | 14.45 |
| ROE: | -48.33 | 10.08 | 15.96 |
Estimates